Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure
Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a...
Main Authors: | , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Public Library of Science
2017
|
Online Access: | http://hdl.handle.net/1721.1/108114 https://orcid.org/0000-0003-3491-4962 |
_version_ | 1826199870996742144 |
---|---|
author | Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann |
author2 | Massachusetts Institute of Technology. Department of Biology |
author_facet | Massachusetts Institute of Technology. Department of Biology Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann |
author_sort | Wang, Xinchen |
collection | MIT |
description | Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a meta-analysis of genome-wide association studies and follow-up genotyping in independent populations. We identified and replicated an association for a genetic variant on chromosome 5q22 with 36% increased risk of death in subjects with heart failure (rs9885413, P = 2.7x10⁻⁹. We provide evidence from reporter gene assays, computational predictions and epigenomic marks that this polymorphism increases activity of an enhancer region active in multiple human tissues. The polymorphism was further reproducibly associated with a DNA methylation signature in whole blood (P = 4.5x10⁻⁴⁰) that also associated with allergic sensitization and expression in blood of the cytokine TSLP (P = 1.1x10⁻⁴). Knockdown of the transcription factor predicted to bind the enhancer region (NHLH1) in a human cell line (HEK293) expressing NHLH1 resulted in lower TSLP expression. In addition, we observed evidence of recent positive selection acting on the risk allele in populations of African descent. Our findings provide novel genetic leads to factors that influence mortality in patients with heart failure. |
first_indexed | 2024-09-23T11:27:08Z |
format | Article |
id | mit-1721.1/108114 |
institution | Massachusetts Institute of Technology |
language | en_US |
last_indexed | 2024-09-23T11:27:08Z |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | dspace |
spelling | mit-1721.1/1081142022-10-01T03:44:20Z Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann Massachusetts Institute of Technology. Department of Biology Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann Failure of the human heart to maintain sufficient output of blood for the demands of the body, heart failure, is a common condition with high mortality even with modern therapeutic alternatives. To identify molecular determinants of mortality in patients with new-onset heart failure, we performed a meta-analysis of genome-wide association studies and follow-up genotyping in independent populations. We identified and replicated an association for a genetic variant on chromosome 5q22 with 36% increased risk of death in subjects with heart failure (rs9885413, P = 2.7x10⁻⁹. We provide evidence from reporter gene assays, computational predictions and epigenomic marks that this polymorphism increases activity of an enhancer region active in multiple human tissues. The polymorphism was further reproducibly associated with a DNA methylation signature in whole blood (P = 4.5x10⁻⁴⁰) that also associated with allergic sensitization and expression in blood of the cytokine TSLP (P = 1.1x10⁻⁴). Knockdown of the transcription factor predicted to bind the enhancer region (NHLH1) in a human cell line (HEK293) expressing NHLH1 resulted in lower TSLP expression. In addition, we observed evidence of recent positive selection acting on the risk allele in populations of African descent. Our findings provide novel genetic leads to factors that influence mortality in patients with heart failure. National Heart, Lung, and Blood Institute (HHSN268201100005C) National Heart, Lung, and Blood Institute (HHSN268201100006C) National Heart, Lung, and Blood Institute (HHSN268201100007C) National Heart, Lung, and Blood Institute (HHSN268201100008C) National Heart, Lung, and Blood Institute (HHSN268201100009C) National Heart, Lung, and Blood Institute (HHSN268201100010C) National Heart, Lung, and Blood Institute (HHSN268201100011C) National Heart, Lung, and Blood Institute (HHSN268201100012C) National Heart, Lung, and Blood Institute (N01-HC-55015) National Heart, Lung, and Blood Institute (N01-HC-55016) National Heart, Lung, and Blood Institute (N01-HC-55018) National Heart, Lung, and Blood Institute (N01-HC-55019) National Heart, Lung, and Blood Institute (N01-HC-55020) National Heart, Lung, and Blood Institute (N01-HC-55021) National Heart, Lung, and Blood Institute (N01-HC-55022) National Heart, Lung, and Blood Institute (R01HL087641) National Heart, Lung, and Blood Institute (R01HL59367) National Heart, Lung, and Blood Institute (R01HL086694) National Human Genome Research Institute (U.S.) (U01HG004402) United States. National Institutes of Health (HHSN268200625226C) United States. National Institutes of Health (UL1RR025005) National Heart, Lung, and Blood Institute (HHSN268201200036C) National Heart, Lung, and Blood Institute (N01HC55222) National Heart, Lung, and Blood Institute (HHSN268200800007C) National Heart, Lung, and Blood Institute (N01HC85079) National Heart, Lung, and Blood Institute (N01HC85080) National Heart, Lung, and Blood Institute (N01HC85081) National Heart, Lung, and Blood Institute (N01HC85082) National Heart, Lung, and Blood Institute (N01HC85083) National Heart, Lung, and Blood Institute (N01HC85086) National Heart, Lung, and Blood Institute (U01HL080295) National Science Foundation (U.S.) (R01HL087652) National Heart, Lung, and Blood Institute (R01HL105756) National Heart, Lung, and Blood Institute (R01HL103612) National Heart, Lung, and Blood Institute (R01HL120393) National Institute on Aging (R01AG023629) National Center for Advancing Translational Sciences (U.S.) (UL1TR000124) National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) (DK063491) National Heart, Lung, and Blood Institute (N01-HC-25195) National Heart, Lung, and Blood Institute (2K24HL04334) National Heart, Lung, and Blood Institute (R01HL077477) National Heart, Lung, and Blood Institute (R01HL093328) National Heart, Lung, and Blood Institute (NIH R01HL105993) National Institute on Aging (N01AG62101) National Heart, Lung, and Blood Institute (N01AG62103) National Heart, Lung, and Blood Institute (N01AG62106) National Institute on Aging (1R01AG032098-01A1) United States. National Institutes of Health (HHSN268200782096C) National Cancer Institute (U.S.) (CA-34944) National Cancer Institute (U.S.) (CA-40360) National Cancer Institute (U.S.) (CA-097193) National Heart, Lung, and Blood Institute (HL-26490) National Heart, Lung, and Blood Institute (HL-34595) 2017-04-13T17:20:12Z 2017-04-13T17:20:12Z 2016-05 2015-09 Article http://purl.org/eprint/type/JournalArticle 1553-7404 1553-7390 http://hdl.handle.net/1721.1/108114 Smith, J. Gustav; Felix, Janine F.; Morrison, Alanna C.; Kalogeropoulos, Andreas; Trompet, Stella; Wilk, Jemma B.; Gidlöf, Olof; et al. “Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure.” Edited by Samuli Ripatti. PLOS Genetics 12, no. 5 (May 5, 2016): e1006034. https://orcid.org/0000-0003-3491-4962 en_US http://dx.doi.org/10.1371/journal.pgen.1006034 PLOS Genetics CC0 1.0 Universal https://creativecommons.org/publicdomain/zero/1.0/ application/pdf Public Library of Science PLOS |
spellingShingle | Wang, Xinchen Kellis, Manolis Boyer, Laurie Ann Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title_full | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title_fullStr | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title_full_unstemmed | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title_short | Discovery of Genetic Variation on Chromosome 5q22 Associated with Mortality in Heart Failure |
title_sort | discovery of genetic variation on chromosome 5q22 associated with mortality in heart failure |
url | http://hdl.handle.net/1721.1/108114 https://orcid.org/0000-0003-3491-4962 |
work_keys_str_mv | AT wangxinchen discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure AT kellismanolis discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure AT boyerlaurieann discoveryofgeneticvariationonchromosome5q22associatedwithmortalityinheartfailure |